Views
11 months ago

2009 Scientific Report

  • Text
  • Institute
  • Scientific
  • Molecular
  • Laboratory
  • Tumor
  • Signaling
  • Michigan
  • Biology

Van Andel Research

Van Andel Research Institute | Scientific Report 4

Van Andel Research Institute ® The NEW Alliance for Precision Medicine About Van Andel Research Institute Dr. George Vande Woude Director of VARI’s Laboratory of Molecular Oncology On December 1, 2009, Van Andel Research Institute (VARI) and the Translational Genomics Research Institute (TGen) will complete a strategic alliance and affiliation agreement, enabling both to maximize their contributions to science and health. Under the agreement, Dr. Jeffrey Trent, TGen’s President and Research Director, also will become VARI’s President and Research Director. Dr. Trent will replace Dr. George Vande Woude, who in 1998 was appointed the founding Director of VARI. Dr. Vande Woude, a member of the prestigious National Academy of Sciences, will remain at VARI as head of the Laboratory of Molecular Oncology, allowing him to achieve a long-held desire to return to the lab full-time. Dr. Jeffrey Trent President and Research Director, VARI and TGen Established by Jay and Betty Van Andel in 1996, Van Andel Institute (VAI) is an independent research and educational organization based in Grand Rapids, Michigan, dedicated to preserving, enhancing and expanding the frontiers of medical science, and to achieving excellence in education by probing fundamental issues of education and the learning process. VARI, the research arm of VAI, is dedicated to studying the genetic, cellular and molecular origins of cancer, Parkinson’s and other diseases and working to translate those findings into effective therapies. This is accomplished through the work of over 250 scientists and staff in 18 on-site laboratories, in laboratories in Singapore and Nanjing, and in collaborative partnerships that span the globe. For additional information, visit: www.vai.org About the Translational Genomics Research Institute The Tra nslational Genomics Research Institute (TGen) is a non-profit biomedical research institute based in Phoenix, Arizona, focused on research that can help patients with cancer, neurological disorders, diabetes and other debilitating conditions. Working with a worldwide network of collaborators in the scientific and medical communities, TGen researchers study the genetic components of both common and complex diseases. Through genomic analysis, we learn how DNA, genes and proteins – the microscopic building block of life – can affec t human health. Our 41 lead investigators and nearly 300 support personnel at sites in Phoenix, Scottsdale and Flagstaff , Arizona, are dedicated to improving patient care and quality of life through precision medicine, best defined as the right therapy, for the right patient, at the right time. For additional information, visit: www.tgen.org

Publications by Year